Foundation for Angelman Syndrome Therapeutics Enters Partnership with Rush University for Research Center
source: unsplash.com

Foundation for Angelman Syndrome Therapeutics Enters Partnership with Rush University for Research Center

  The Foundation for Angelman Syndrome Therapeutics (FAST) recently entered a partnership with Rush University in order to establish a clinical trial and translational research center for rare neurodevelopmental disorders.…

Continue Reading Foundation for Angelman Syndrome Therapeutics Enters Partnership with Rush University for Research Center

At 49, She Got Her PhD to Help Her Son With Angelman. Now, She Created COMBINEDBrain To Help Many Related Rare Diseases.

As originally reported in Angelman Syndrome News, Terry Jo Bichell is a PhD researcher, former director and scientific officer of the Angelman Biomarkers and Outcomes Measures Alliance and Tennessee's ambassador…

Continue Reading At 49, She Got Her PhD to Help Her Son With Angelman. Now, She Created COMBINEDBrain To Help Many Related Rare Diseases.
These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies
EliasSch / Pixabay

These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies

According to a story from BioSpace, the gene therapy companies Sarepta Therapeutics, Inc. and StrideBio, Inc. have recently announced the completion of a licensing and collaboration agreement that could lead…

Continue Reading These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies